HOME >> BIOLOGY >> NEWS
ISN's Nexus Hypertension-Kidney debate

The Infinite Gain: three decades on

Delivering the Opening Plenary Lecture, John E. Hall, Guyton Professor, Chairman of Physiology and Biophysics and Director of the Center of Excellence in Cardiovascular -Renal Research (University of Mississippi Medical Center), will present on Renal-Pressure Natriuresis - An Infinite Gain Feedback Mechanism fo Long-Term Blood Pressure Regulation"

The Nexus Plenaries to follow will aim to map the relevance of Guyton's pioneering work in both present and future contexts, spanning a wide range of timely and related topics:

Genomics: Hap Map Project (Aravinda Chakravarti, USA), Proteomics of Renal Exosomes (Mark Knepper, USA), Epidemiology: the Developmental Origins of Adult Disease (David JP Barker, UK), and Circadian control of genes, cells, and organs (Ueli Schibler, Switzerland).

Biomarkers, regultators and risk factors

In alignment with the unique Nexus format, the core program will incorporate three sessions dedicated to both the bench and the 'bedside' levels. Promoting a highly multidisciplnary approach, Hypertension and the Kidney will offer it series of three parallel sessions to deliver the cutting edge basic and clinical discovery aimed at researchers, physicians and clnicians respectively. Mirrored at both levels, the Baisc Science and Clinical Sessions will offer in-depth, rigorous updates on and around RAAS and Cardiovascular Risk, Proteinuria and Hypertension and Diuretics Revisited.

The translational sessions: the jewel in the Nexus crown

The three Translational Sessions - the key and final phase in closing the bench to bedside gap - are naturally offered to all participants. Set to signpost future directions and concrete solutions in research, patient treatment and care - the ultimate step toward addressing real day to day clinical challenges. These sessions will tackle: Guyton's Concept in 2007, Salt-Regulation Effec
'"/>

Contact: Amanda Wren
amanda.wren@isn-online.org
32-473-938-672
International Society of Nephrology
10-May-2007


Page: 1 2

Related biology news :

1. Prize winners announced at ISNs World Congress of Nephrology
2. Research ends debate over benefits of butterfly defenses
3. Lawyers and ethicists debate ashley treatment in open forum
4. Center for Science Writings debate: Redesigning Humanity, March 21
5. Scientists debate the neurobiological underpinnings of amnesia
6. Genome archaeology illuminates the genetic engineering debate
7. Math and fossils resolve a debate on dinosaur metabolism
8. Physics and biology team up to tackle protein folding debate
9. Researchers say environmental pollution is important piece of social justice debate
10. Different but equal: Settling the dosage compensation debate
11. Study continues the debate on the nature of bisexual men

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ISN Nexus Hypertension Kidney debate

(Date:7/2/2015)... Sweden , July 2, 2015 ... sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... 2015. The sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of approximately ...
(Date:6/30/2015)... Pa. , June 30, 2015 ... the company as CEO to help further develop Genisphere,s ... wealth of partnering experience, having spent much of the ... including Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. ... focus on Technology and Biotech Corporate Finance. He graduated ...
(Date:6/26/2015)... -- ATL Technology, LLC, a top provider of electromechanical contract ... solutions, headquartered in Springville, Utah , has ... corporation with locations in Santa Clara, ... ). This acquisition will incorporate MedConx,s manufacturing ... Technology,s existing facility in Costa Rica , ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... of benzene. Benzene is processed to get such derivatives as ethylbenzene, a precursor ... are principally used within the automotive industry for the production of tyres and ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Nine field days ... Illinois and Indiana. Hosted by the Soil Health Partnership , the field days ... environmental benefits while potentially increasing farm productivity and income. , Brent Bible has practiced ...
(Date:8/3/2015)... E-QURE Corp. (OTCQB: EQUR), a ... Signal Therapy device ("BST Device"), a new and novel ... chronic wounds, today announced that the Company has signed ... specializing in medical devices, for the marketing and distribution ... 70 years old, sales, marketing and distribution company in ...
(Date:8/3/2015)... 3, 2015 According to a ... Cell Culture: Asia to Witness ... the global 3D cell culture market was valued at US$ 586.1 ... a CAGR of 29.1% to account for US$ 2,717.6 ... TOC:  http://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp 3D cell culture refers ...
Breaking Biology Technology:World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 3Soil Health Field Days Kick Off Throughout Midwest 2Soil Health Field Days Kick Off Throughout Midwest 3E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4
Cached News: